Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, most people taking Mounjaro can use Fybogel (ispaghula husk) at the same time. There is no known pharmacokinetic interaction between tirzepatide and ispaghula husk, and fibre supplementation is often a practical way to manage constipation, which is one of the more common gastrointestinal side effects of Mounjaro. That said, how and when you take Fybogel alongside a once-weekly injection does matter, and for anyone with gut conditions or other medicines in the mix, a quick word with your prescriber is worth more than any general answer. Mounjaro is a prescription-only medicine, and decisions about managing its side effects sit properly with the clinician who is overseeing your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This concern comes up regularly, and it is understandable. Bulk-forming fibre supplements can reduce the absorption of certain oral medicines by binding to them in the gut. The key distinction with Mounjaro is that tirzepatide is injected subcutaneously, not swallowed. It bypasses the digestive tract entirely on its way into the bloodstream. Ispaghula husk, sitting in the bowel, has no meaningful opportunity to interfere with it.
What Fybogel does do is draw water into the large intestine to bulk up stool. Mounjaro, meanwhile, works partly by slowing how quickly food leaves the stomach. These two mechanisms operate in different parts of the gut and at different stages of digestion. There is no clinical evidence of a relevant interaction between them.
That said, slowed gastric motility does mean your gut is working more slowly overall, so adequate fluid intake becomes more important, not less. The NHS tirzepatide medicines page highlights constipation as a reported side effect, and standard guidance for bulk-forming laxatives consistently stresses that they must be taken with a full glass of water. Dry-swallowing or taking Fybogel with too little fluid can worsen things rather than help.
Tirzepatide activates both GIP and GLP-1 receptors, and one of its effects is a significant slowing of gastric emptying. For most people this is what reduces appetite so effectively. It also means food and waste move through the entire digestive system more slowly, and that slower transit is a direct route to constipation for many patients.
The effect tends to be most noticeable after starting treatment or after each dose step. For some people it settles within a couple of weeks. For others it becomes an ongoing background issue, particularly if dietary fibre intake has fallen because appetite itself has dropped.
Fybogel works well here precisely because it is not a stimulant laxative. It does not force the bowel to contract; it simply gives the stool more bulk and softness, which suits a system that is moving slowly rather than one that has stopped responding entirely. Drinking the full recommended amount of fluid with each sachet is non-negotiable in this context.
If you are also thinking about general eligibility or how your existing health picture fits with Mounjaro, the BMI criteria for Mounjaro page sets out the licensed thresholds clearly, including guidance on whether a BMI of 27 qualifies you for treatment.
Fybogel is a sensible first step for mild, uncomplicated constipation. There are situations, though, where self-managing with an over-the-counter supplement is not the right move.
Severe stomach pain is one. The MHRA issued a Drug Safety Update in January 2026 flagging acute pancreatitis as an infrequent but serious risk with GLP-1 medicines: severe, persistent abdominal pain that may radiate to the back needs prompt medical attention, not a sachet of Fybogel. That is a different symptom pattern from ordinary constipation, but it is worth knowing the distinction before you attribute any gut discomfort to simple slow transit.
Constipation that has lasted more than two weeks, or that is getting worse despite fibre and fluid, also warrants a prescriber conversation. So does any situation involving a bowel condition already in your medical history, such as diverticular disease, inflammatory bowel disease or a history of bowel obstruction. Fybogel is generally contraindicated where there is a risk of gut blockage, and Mounjaro's slowing effect on motility is a reason to be cautious.
For people already established on another medicine that affects gut transit, or who are managing chronic kidney disease alongside treatment, the picture can be more complex. The page on taking Mounjaro with CKD covers some of those interactions.
Fybogel is typically taken twice a day, ideally after meals. If you are also taking other oral medicines at the same time, give those at least a couple of hours' gap from your Fybogel dose, because the fibre can reduce the absorption of some drugs when taken together. This is not specific to Mounjaro (which is injected), but it is relevant if you have other tablets in your routine.
Hydration deserves a proper mention here. Mounjaro reduces thirst cues in many patients at the same time as reducing appetite, and it is easy to drift into a state of mild dehydration without noticing. When you then add a bulk-forming supplement that relies on drawing water into the gut, insufficient fluid intake is the most common reason Fybogel makes things worse rather than better. A practical rule: if you are not drinking the equivalent of six to eight cups of water across the day, more fibre without more fluid is unlikely to help.
One thing patients sometimes flag is timing around bigger life events, and hormonal cycles can be part of that picture too, with some patients asking whether it is safe to take Mounjaro during their period. If a dose increase is landing over a bank holiday, or you are planning to travel and think constipation might be an issue, it is worth stocking both Fybogel and your usual hydration routine before you go rather than scrambling for a pharmacy abroad.
For a broader look at how supplements and other products interact with tirzepatide, the page covering NMN and Mounjaro takes a similar evidence-based approach. And if you have questions about whether you are suitable for treatment in the first place, starting Mounjaro covers eligibility in detail.
At nume, every patient is reviewed by a real prescriber before and at each repeat order. Our prescribers field questions about managing side effects routinely, and that conversation is part of the service rather than an extra. If constipation is something you want to discuss before or during treatment, speak to our prescribers through a free consultation and get a personal answer rather than a general one.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.